Journal
CELL REPORTS
Volume 23, Issue 12, Pages 3492-3500Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2018.05.074
Keywords
-
Categories
Funding
- Australian Postgraduate Award
- Australian Research Council (ARC) [DP160100011]
- European Research Council [669237]
- Royal Society
- Boehringer Ingelheim Fonds
- UK Biotechnology and Biochemical Sciences Research Council
- Wellcome Trust
- Cambridge Centre for Misfolding Diseases
- Marie Curie individual fellowship
- Christ's College, Cambridge, UK
- Fondazione Umberto Veronesi post-doctoral fellowship
- MRC [UKDRI-2003] Funding Source: UKRI
Ask authors/readers for more resources
The aberrant aggregation of alpha-synuclein is associated with several human diseases, collectively termed the alpha-synucleinopathies, which includes Parkinson's disease. The progression of these diseases is, in part, mediated by extracellular alpha-synuclein oligomers that may exert effects through several mechanisms, including prion-like transfer, direct cytotoxicity, and pro-inflammatory actions. In this study, we show that two abundant extracellular chaperones, clusterin and alpha(2)-macroglobulin, directly bind to exposed hydrophobic regions on the surface of alpha-synuclein oligomers. Using single-molecule fluorescence techniques, we found that clusterin, unlike alpha(2)-macroglobulin, exhibits differential binding to alpha-synuclein oligomers that may be related to structural differences between two previously described forms of alpha S oligomers. The binding of both chaperones reduces the ability of the oligomers to permeabilize lipid membranes and prevents an oligomer-induced increase in ROS production in cultured neuronal cells. Taken together, these data suggest a neuroprotective role for extracellular chaperones in suppressing the toxicity associated with alpha-synuclein oligomers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available